Back to Authors

Bredella, Miriam A.

https://orcid.org/0000-0001-5482-0440

Mayo Clinic

Harvard University

Citations 4

Changes in serum cortisol levels after 10 days of overfeeding and fasting
Colling, Caitlin , Bredella, Miriam A. , Fazeli, Pouneh K. , Pachón-Peña, Gisela, Miller, Karen K. , Singh, Ravinder J. , Rosen, Clifford J.

American Journal of Physiology-Endocrinology and Metabolism | April 13, 2023 | Volume: 324 | Issue: 6 | Pages: E506-E513

10.1152/ajpendo.00181.2022 Get It

Overfeeding and fasting both increase circulating free cortisol levels and appear to alter the balance between cortisol and its inactive metabolite, cortisone. The effect of fasting on free cortisol levels is modified by sex. Further study is needed to determine the mechanisms driving the increases in cortisol.
Management of neurofibromatosis type 1-associated plexiform neurofibromas
Fisher, Michael J. , Blakeley, Jaishri O. , Dombi, Eva , Akshintala, Srivandana , Belzberg, Allan J. , Bornhorst, Miriam , Bredella, Miriam A. , Ferner, Rosalie E. , Gross, Andrea M. , Harris, Gordon J. , Listernick, Robert , Ly, Ina , Martin, Staci , Mautner, Victor F., Salamon, Johannes, Salerno, Kilian , Spinner, Robert J. , Staedtke, Verena , Ullrich, Nicole J. , Upadhyaya, Meena , Wolters, Pamela L. , Widemann, Brigitte C. , Dombi, Eva , Bornhorst, Miriam , Blakeley, Jaishri O , Gross, Andrea M , Weiss, Brian , Ahlawat, Shivani , Cai, Wenli , Mautner, Victor‐F., Yohay, Kaleb

Neuro-Oncology | June 3, 2022 | Volume: 24 | Issue: 11 | Pages: 1827-1844

10.1093/neuonc/noac146 Get It

Abstract Plexiform Neurofibromas (PN) are a common manifestation of the genetic disorder neurofibromatosis type 1 (NF1). These benign nerve sheath tumors often cause significant morbidity, with treatment options limited historically to surgery. There have been tremendous advances over the past two decades in our understanding of PN, and the recent regulatory approvals of the MEK inhibitor selumetinib are reshaping the landscape for PN management. At present, there is no agreed upon PN definition, diagnostic evaluation, surveillance strategy, or clear indications for when to initiate treatment and selection of treatment modality. In this review, we address these questions via consensus recommendations from a panel of multidisciplinary NF1 experts.
Aneurysmal bone cyst with an unusual clinical presentation and a novel VDR‐USP6 fusion
Papke, David , Bredella, Miriam A. , Lozano‐Calderón, Santiago A. , Oliveira, André M. , Lennerz, Jochen K. , Nielsen, G. Petur , Papke, David J , Lennerz, Jochen

Genes, Chromosomes and Cancer | August 9, 2021 | Volume: 60 | Issue: 12 | Pages: 833-836

10.1002/gcc.22989 Get It

AbstractAneurysmal bone cyst is a benign bone neoplasm that most commonly arises from the metaphyses of long bones in the first and second decades of life. Here, we describe a case of an aneurysmal bone cyst that occurred in the distal tibial diaphysis of a 72‐year‐old female that was concerning for malignancy on imaging, demonstrating cortical breakthrough and soft tissue extension. Histologically, the tumor showed the characteristic morphologic features of aneurysmal bone cyst. Fluorescence in situ hybridization was positive for USP6 rearrangement, and RNA sequencing revealed a USP6 gene fusion with VDR, a novel partner that encodes the vitamin D receptor and that has not been implicated previously in human neoplasia. This case highlights the diagnostic challenges presented by aneurysmal bone cyst in elderly adults, and it expands the genetic spectrum of USP6 rearrangements.